1. Home
  2. VMD vs SMTI Comparison

VMD vs SMTI Comparison

Compare VMD & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viemed Healthcare Inc.

VMD

Viemed Healthcare Inc.

N/A

Current Price

$8.73

Market Cap

465.4M

Sector

N/A

ML Signal

N/A

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$35.15

Market Cap

313.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VMD
SMTI
Founded
2006
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
465.4M
313.5M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
VMD
SMTI
Price
$8.73
$35.15
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$34.00
AVG Volume (30 Days)
332.5K
296.6K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
32.14
N/A
EPS
0.13
N/A
Revenue
$270,280,000.00
$15,586,976.00
Revenue This Year
$17.88
$17.31
Revenue Next Year
$14.98
$12.48
P/E Ratio
$67.62
N/A
Revenue Growth
20.52
32.47
52 Week Low
$6.05
$16.05
52 Week High
$12.61
$35.53

Technical Indicators

Market Signals
Indicator
VMD
SMTI
Relative Strength Index (RSI) 37.82 75.49
Support Level $8.49 $33.99
Resistance Level $8.94 N/A
Average True Range (ATR) 0.25 0.27
MACD 0.07 -0.25
Stochastic Oscillator 30.82 71.74

Price Performance

Historical Comparison
VMD
SMTI

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: